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AbsTRACT
Several studies suggest a strong familial aggregation for cluster headache (CH), but so far none of them have included subjects with probable 
cluster headache (PCH) in accordance with the International Classification of Headache Disorders. Objective: To identify cases of probable 
cluster headache and to assess the familial aggregation of cluster headache by including these subjects. Method: Thirty-six patients attend-
ing a headache consultation and diagnosed with trigeminal autonomic headaches were subjected to a questionnaire-based interview. A tele-
phone interview was also applied to all the relatives who were pointed out as possibly affected as well as to some of the remaining relatives. 
Results: Twenty-four probands fulfilled the criteria for CH or PCH; they had 142 first-degree relatives, of whom five were found to have CH or 
PCH, including one case of CH sine headache. The risk for first-degree relatives was observed to be increased by 35- to 46-fold. Conclusion: 
Our results suggest a familial aggregation of cluster headache in the Portuguese population. 
Keywords: cluster headache, probable cluster headache, familial aggregation, cluster headache sine headache, first-degree relatives.
REsumo
Diversos artigos sugerem uma significativa agregação familiar da cefaleia em salvas (CH) embora nenhum tenha incluído indivíduos com 
provável cefaleia em salvas (PCH), segundo critérios da Classificação Internacional de Cefaleias (ICHD-II). Objetivo: Encontrar casos de pro-
vável cefaleia em salvas e avaliar a agregação familiar da cefaleia em salvas incluindo também esses indivíduos. Método: Foi aplicado um 
questionário por telefone a 36 doentes que frequentaram uma Consulta de Cefaleias com diagnóstico de cefaleia trigémino-autonómica. 
Todos os familiares de primeiro grau referidos como possivelmente afetados e alguns dos restantes foram entrevistados por telefone. Re-
sultados: Em 24 doentes foi diagnosticada CH ou PCH e estes tinham 142 familiares de primeiro grau, cinco dos quais foram diagnosticados 
como CH ou PCH, incluindo um caso de CH sem cefaleias. O risco para familiares de primeiro grau foi 35-46 vezes superior ao da população 
geral. Conclusão: Nossos resultados sugerem a existência de uma agregação familiar da cefaleia em salvas na população portuguesa.
Palavras-chave: cefaleia em salvas, provável cefaleia em salvas, agregação familiar, cefaleia em salvas sem cefaleia, familiares de 
primeiro grau.
Cluster headache (CH) is a form of trigeminal auto­
nomic headache defined by a set of criteria that include 
a severe, unilateral pain, usually located around the or­
bit, combined with disautonomic manifestations affec­
ting the same region, and usually accompanying the pain1. 
The International Classification of Headache Disorders 
(ICHD­II) also recognizes the concept of probable clus-
ter headache (PCH), which requires the fulfillment of all 
CH criteria but one. Cases presenting with these “incom­
plete” forms have already been reported, and in some of 
these, a conversion into a “complete” form or vice­versa 
has  occurred2,3. The estimate for the prevalence of CH 
among the general population ranges from 56 to 401 per 
100.0004­11. A Portuguese population­based study found 
one individu al with CH and one case of PCH among a sample 
of 2008 subjects12. 
Familial aggregation of this disease has been the subject of 
at least four studies; the results have suggested an increased 
risk for first-degree relatives ranging from 14- to 45-fold when 
compared to the general population13­16. These studies inclu-
ded only the patients and relatives fulfilling the complete set 
of criteria for CH.
Based on the results of this study the following hypothesis 
emerged: if both CH and PCH cases were included, a stronger 
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familial aggregation could be determined. Such findings 
would probably contribute to strengthening the interest in 
finding possible genetic factors implied in the pathogenesis 
of this disease.
The main objectives of this study were to find cases of 
PCH including CH sine headache among relatives and to 
evaluate the familial aggregation of a broader spectrum of 
CH in a sample of the Portuguese population.
mEThod
Patient’s selection
From the population evaluated in the Outpatient Hea ­
dache Clinic of Hospital Santo António (Porto, Portugal) du­
ring the last 15 years, 77 consecutive and unrelated patients 
suspected of having a trigeminal autonomic headache were 
selected. 
data collection 
The first step was to contact the patients in order to 
evaluate a structured questionnaire to allow the fulfillment of 
the diagnostic criteria for CH. The contact was made by tele­
phone and during the contact the patients were asked if their 
first-degree relatives (parents, siblings, and offspring) have 
ever had a headache similar to their own or, alternatively, if 
their relatives have ever experienced paroxisms of disauto­
nomic features compatible with CH, even in the absence of 
the headache itself. Finally, the telephone number of the first-
degree relatives was requested. The second stage of this study 
consisted of interviewing the first-degree relatives to screen 
them for recurrent headaches and, in case of a positive fin-
ding, to try to match the symptoms with the diagnostic crite­
ria for CH. The deceased relatives referred by the probands as 
suspects were not considered as such. Only 12 of the relatives 
not considered suspects were available for interview. None of 
the 20 interviewed relatives were observed and examined by 
a neurologist. Therefore, possible secondary causes for their 
symptoms were not excluded. 
Familial aggregation
Evaluation of CH familial aggregation was based on the 
concept of relative risk (RR), which was calculated from the 
ratio between the likelihood of having an affected relative 
considering an affected patient, and the likelihood of having 
a random affected individual in the general population. The 
latter corresponds to the prevalence of the disease among 
the general population. For this purpose, the estimation ob­
tained from a Portuguese population­based study12 was used. 
RR was statistically determined using a univariate analysis 
for categorical variables (c2 test). The level of significance was 
set at 95% and familial aggregation was considered if the RR 
was greater than one. 
Ethical issues
A letter containing the necessary information about this 
study was sent to all of the 77 patients. The Ethics Committee 
of Hospital Santo António approved the project. 
REsuLTs
It was not possible to obtain any response from 41 of the 
initial 77 patients due to several reasons such as death (2), 
refusal to collaborate (6), and incorrect contact details (33). 
Of the 36 subjects interviewed, 7 were excluded because their 
headache did not satisfy the criteria for any of the trigeminal 
autonomic headaches. The remaining 29 patients were classi­
fied as follows: 22 as having CH (82% with an episodic pattern 
and 18% with chronic CH), 2 as PCH and 5 as short­lasting 
unilateral neuralgiform headache attacks with conjunctival 
injection and tearing (SUNCT). Only the 24 patients with CH 
or PCH were considered in the subsequent statistical analysis. 
Seventy­nine percent of these patients were male (Table 1), 
and the mean age of onset was 34 years (standard deviation: 
15,39), ranging from 11 to 70 years.
The 24 probands with CH or PCH had a total of 142 first-
degree relatives. Five patients (21%) had a positive family his­
tory, with 10 possible cases among the group of relatives. Of 
the 142 relatives, 20 (14%) were interviewed, including 8 out 
of the 10 previously designated (the others had died). Three of 
these matched the criteria for CH and two were classified as 
PCH according to the ICHD­II. None of the unsuspected rela­
tives had CH or PCH (Figure 1).
Two scenarios were considered when calculating the RR 
(Table 2). In the first scenario, for all the variables implied in 
the equation, both CH and PCH subjects were included. In 
the second scenario, only those individuals with CH were 
considered. First­degree relatives of probands with CH were 
estimated as having a 35­ to 46­fold increased risk of having 
CH compared with the general population. Both values are 
statistically significant (p<0.05).
Cases among the affected families 
The five affected relatives belonged to the families of only 
three probands.
One of these probands was a 58­year­old female who 
had an episodic CH for 15 years. She had two sisters; one 
aged 56 years and the other aged 61 years. The former had 
Table 1. Demographic characteristics of probands.
Number of 
probands (%)
Age Age of onset
Mean Range Mean Range
Total 24 51 18-76 34 11-70
Male 19 (79) 49 18-76 31 11-65
Female 5 (21) 56 44-74 43 17-70
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symptoms for 30 years, fulfilling all the criteria for CH except 
for the duration: she mentioned periods of pain lasting bet­
ween 2 and 3 days. The second sister seemed to be a case of 
CH sine headache. She denied recurrent headaches, but des­
cribed several episodes lasting about 30 min, during which 
she complained of conjunctival injection, tearing, and ptosis 
exclusively affecting the left eye, without any apparent pre­
cipitant. The proband mentioned that their mother displayed 
similar manifestations but she had already died and was not 
considered as an affected relative. 
The second proband was a 55-year-old male describing 
an episodic CH. He had four siblings, including two males 
who also fulfilled all the criteria for CH.
The third proband, a female aged 45 years, presented an 
episodic CH and had a 51-year-old brother who also fulfilled 
all the criteria for episodic CH. 
dIsCussIon
The demographic characteristics of the patients inclu -
ded in this study were similar to those widely reported. The 
male:female ratio was found to be approximately 4:1, thus 
slightly higher than that described by most authors17,18. The 
age of onset is also superior to what has been reported. While 
most patients present their first features around the third de­
cade of life, the probands in this study had their initial symp­
toms about a decade later. The findings of the two patients 
who began complaining of CH symptoms at an uncommon 
age (11 and 70 years) are noteworthy, although similar cases 
have been previously reported19. The proportion of episodic 
and chronic patterns of CH in this sample (approximately 4:1) 
is also concordant with most studies20.
The high number of cases matching the criteria for 
SUNCT in this study is unexpected, as this type of headache 
is described as very uncommon. According to some authors, 
there may be some shared aspects in the physiopathology of 
the trigeminal autonomic headaches21. Furthermore, there 
are some case reports of successful usage of drugs like vera­
pamil (most commonly used in CH) in patients with SUNCT22. 
While these findings may suggest some overlap between CH 
and SUCNT, it seems more likely that the exceedingly high 
number of cases in our study may be due to the origin of our 
sample (a tertiary headache clinic).
One of the most important aspects of familial aggregation 
studies is the choice of the prevalence estimation, because a 
small prevalence can lead to an overestimation of the rela­
tive risk and vice­versa. We used the data from a Portuguese 
population­based study12 that reported one case of CH and 
another of PCH among 2008 individuals, thus obtaining a 
prevalence of approximately 50/100.000, if only CH cases are 
included. This estimation is similar to those obtained in the 
two San Marino studies5,6 that used a thorough methodology 
and reported the following values: 56 and 69/100.000. Thus, 
the prevalence used in our study seems to be a good indicator 
for the prevalence of CH in southern Europe.
Table 2. Relative risk for first-degree relatives of patients with cluster headache and probable cluster headache. 
Cases included
RR 95% CI
Prevalence Relatives (total) Relatives (affected)
1s
t  s
ce
na
ri
o Condition To fulfill all or all but one 
diagnostic criteria 
Should be related to a proband 
who fulfills all or all but one 
diagnostic criteria
To fulfill all or all but 
one diagnostic criteria
35.21a 14.56–85.14
Value 1:1000 142 5
2n
d  s
ce
na
ri
o Condition To fulfill all the 
diagnostic criteria
Should be related to a proband 
who fulfills all the criteria
To fulfill all the 
diagnostic criteria
46.15a 14.58–146.09
Value 0.5/1000 130 3
RR: relative risk; CI: confidence interval.
a For both RR values, p<0.05.
CH: cluster headache; PCH: probable cluster headache.
Figure 1. Flow chart showing probands and first-degree 
relatives with their clinical diagnosis.
22 subjects with CH 2 cases of PCH
142 first degree 
10 referred by
the probands as
suspects
132 non
suspects
8 interviewed 2 not
interviewed
(deceased)
12
interviewed
120 not
interviewed
9 denied
recurrent
headaches
3 had other
types of
headache
3 had other
types of
headache
2 cases
of PCH
3 cases
of CH
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Considering the reports of cases presenting with PCH that 
later developed a CH3 or vice­versa2, as well as the  suggestion 
of a broader clinical spectrum for CH, it seemed appropriate 
to include individuals who present with PCH, and not just 
CH, in epidemiological studies. In our first scenario we ob­
tained a RR of 35 and for the second a 46­fold increased risk 
for first-degree relatives. The difference between both values 
may be partially explained by the lower prevalence used in 
the second scenario. Thus, the hypothesis of a higher RR with 
the inclusion of PCH subjects was not confirmed. 
The previous four published familial aggregation studies 
reported an increased risk for first-degree relatives ranging 
from approximately 14­ to 45­fold13­16. 
Both Russell et al.13, in Denmark, and Leone et al.14, in 
Italy, used a similar methodology and determined a RR of 14.1 
and 39, respectively, for first-degree relatives. We can identify 
at least four important differences when comparing these 
studies with ours. Firstly, in these studies, only the possibly 
affected relatives were interviewed. Another difference has 
to do with the non­inclusion of PCH subjects. Furthermore, 
they included deceased relatives as long as the description 
provided by the probands was detailed enough to classi­
fy them according to ICHD. Finally, the prevalence used in 
the se studies (69/100.000) was only slightly higher than the 
one considered for our equivalent scenario (50/100.000). The 
samples used by these authors were far larger than ours and 
the confidence intervals were considerably narrower, giving 
an important consistency to their results.
In France, El Amrani et al.15 introduced what seems to be 
a methodological advantage: all first-degree relatives were 
directly interviewed by a neurologist. In the other studies, 
including ours, some affected relatives may have been lost 
 because of a possible underreporting by the probands.
Kudrow and Kudrow16, with a North­American sample, 
found a RR of 45. However, the family history provided by the 
probands was not confirmed by a direct interview with the 
relatives, which may have led to an overestimation of RR. 
The most important limitation of our study is the small 
number of subjects included, which withdraws some consis­
tency to our results, especially when compared with similar 
studies. Furthermore, our sample was collected from a ter­
tiary center, and thus a direct extrapolation for the general 
population cannot be done.
Only a small proportion (14%) of the first-degree relatives 
was interviewed in this study and the remaining relatives 
were considered to be unaffected (according to the infor­
mation provided by the probands). However, taking into ac­
count the possibility that there could have been some affec-
ted relatives among those not interviewed, their inclusion in 
the equation would have resulted in an even greater RR. Also, 
if this calculation was made using only the relatives who were 
interviewed, the RR value would have been higher. Thus, this 
limitation may have lead to an underestimation of the RR in 
this study.
Telephonic interviews have been described as a valid ins­
trument in familial aggregation studies and prevalence stud­
ies23,24, particularly because they allow the clarification of 
difficult or ambiguous questions. So the use of telephone in­
terviews seems to be an important advantage of our study. 
Another positive aspect is the use of a prevalence estimation 
obtained from a similar population. 
Finally, to the best of our knowledge, our study is the first 
one that includes individuals with PCH, which seems to be a 
major advantage given the reports of a broader spectrum for 
the disease. Although we have not confirmed a greater RR 
with this addition, our results provide significant evidence of 
a strong familial aggregation, thus reinforcing the theory of a 
genetic basis for CH. In the future, a larger study with a simi­
lar methodology may be important to support these results.
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